BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38846250)

  • 1. Beyond the Norm: A Report of a Rare Case of Sodium Channel 8 Alpha (SCN8A) Gene-Related Epilepsy Unveiled in a Nine-Year-Old Child.
    K SSNSP; Vagha K; Varma A; Javvaji CK; Bhanushali K; Malik A; Handargule A
    Cureus; 2024 May; 16(5):e59775. PubMed ID: 38846250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of
    Ottolini M; Barker BS; Gaykema RP; Meisler MH; Patel MK
    J Neurosci; 2017 Aug; 37(32):7643-7655. PubMed ID: 28676574
    [No Abstract]   [Full Text] [Related]  

  • 3. The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin.
    Barker BS; Ottolini M; Wagnon JL; Hollander RM; Meisler MH; Patel MK
    Epilepsia; 2016 Sep; 57(9):1458-66. PubMed ID: 27375106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes.
    Gardella E; Møller RS
    Epilepsia; 2019 Dec; 60 Suppl 3():S77-S85. PubMed ID: 31904124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey.
    Cutts A; Savoie H; Hammer MF; Schreiber J; Grayson C; Luzon C; Butterfield N; Pimstone SN; Aycardi E; Harden C; Yonan C; Jen E; Nguyen T; Carmack T; Haubenberger D
    Seizure; 2022 Apr; 97():50-57. PubMed ID: 35325842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NBI-921352, a first-in-class, Na
    Johnson JP; Focken T; Khakh K; Tari PK; Dube C; Goodchild SJ; Andrez JC; Bankar G; Bogucki D; Burford K; Chang E; Chowdhury S; Dean R; de Boer G; Decker S; Dehnhardt C; Feng M; Gong W; Grimwood M; Hasan A; Hussainkhel A; Jia Q; Lee S; Li J; Lin S; Lindgren A; Lofstrand V; Mezeyova J; Namdari R; Nelkenbrecher K; Shuart NG; Sojo L; Sun S; Taron M; Waldbrook M; Weeratunge D; Wesolowski S; Williams A; Wilson M; Xie Z; Yoo R; Young C; Zenova A; Zhang W; Cutts AJ; Sherrington RP; Pimstone SN; Winquist R; Cohen CJ; Empfield JR
    Elife; 2022 Mar; 11():. PubMed ID: 35234610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN8A-related developmental and epileptic encephalopathy with ictal asystole requiring cardiac pacemaker implantation.
    Negishi Y; Aoki Y; Itomi K; Yasuda K; Taniguchi H; Ishida A; Arakawa T; Miyamoto S; Nakashima M; Saitsu H; Saitoh S
    Brain Dev; 2021 Aug; 43(7):804-808. PubMed ID: 33827760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
    Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
    Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genetic spectrum in Chinese children with SCN8A-related disorders.
    Hu C; Luo T; Wang Y
    Seizure; 2022 Feb; 95():38-49. PubMed ID: 34979445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy.
    Stringer RN; Jurkovicova-Tarabova B; Souza IA; Ibrahim J; Vacik T; Fathalla WM; Hertecant J; Zamponi GW; Lacinova L; Weiss N
    Mol Brain; 2021 Aug; 14(1):126. PubMed ID: 34399820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCN8A Epilepsy, Developmental Encephalopathy, and Related Disorders.
    Talwar D; Hammer MF
    Pediatr Neurol; 2021 Sep; 122():76-83. PubMed ID: 34353676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized tonic seizures with autonomic signs are the hallmark of SCN8A developmental and epileptic encephalopathy.
    Trivisano M; Pavia GC; Ferretti A; Fusco L; Vigevano F; Specchio N
    Epilepsy Behav; 2019 Jul; 96():219-223. PubMed ID: 31174070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs.
    Guo QB; Zhan L; Xu HY; Gao ZB; Zheng YM
    Acta Pharmacol Sin; 2022 Dec; 43(12):3139-3148. PubMed ID: 35902765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.
    Baker EM; Thompson CH; Hawkins NA; Wagnon JL; Wengert ER; Patel MK; George AL; Meisler MH; Kearney JA
    Epilepsia; 2018 Jun; 59(6):1166-1176. PubMed ID: 29782051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures.
    Wang J; Gao H; Bao X; Zhang Q; Li J; Wei L; Wu X; Chen Y; Yu S
    BMC Med Genet; 2017 Sep; 18(1):104. PubMed ID: 28923014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
    Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
    Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin-Positive Interneurons Contribute to Seizures in
    Wengert ER; Miralles RM; Wedgwood KCA; Wagley PK; Strohm SM; Panchal PS; Idrissi AM; Wenker IC; Thompson JA; Gaykema RP; Patel MK
    J Neurosci; 2021 Nov; 41(44):9257-9273. PubMed ID: 34544834
    [No Abstract]   [Full Text] [Related]  

  • 18. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.
    Wengert ER; Saga AU; Panchal PS; Barker BS; Patel MK
    Neuropharmacology; 2019 Nov; 158():107699. PubMed ID: 31278928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epilepsy Res; 2019 Dec; 158():106222. PubMed ID: 31675620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.